GARRETT SOMERS: Open Payments
NPI 1609338631 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 8 payments from 4 companies in 2025. Trend: 2023 $15 · 2024 $39 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 2 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
Products named: AMVUTTRA, Kerendia, FARXIGA, JARDIANCE.
Industry payments across GA — which companies pay providers there.
